Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
270.4 USD | +0.38% | +0.74% | -5.94% |
03:38pm | Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza | DJ |
Apr. 22 | Wall Street: tech and SOXX in free fall this week | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.94% | 144B | |
+25.69% | 653B | |
+26.30% | 556B | |
-6.36% | 354B | |
+20.57% | 331B | |
+4.58% | 296B | |
+12.49% | 233B | |
+5.53% | 201B | |
-9.69% | 193B | |
-11.74% | 143B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Wells Fargo Upgrades Amgen to Overweight From Equalweight, Adjusts Price Target to $265 From $275